Related Experiment Video

Updated: Jan 17, 2026

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

11.3K

Beta-synuclein: a dynamic biomarker and modulator in neurodegenerative dementia

Marco Bucci1,2

  • 1Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden Marco.bucci@ki.se.

Journal of Neurology, Neurosurgery, and Psychiatry
|September 23, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Alzheimer's diseaseAmyloidCognitionDementiaLewy body dementia

More Related Videos

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
09:44

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Published on: June 2, 2019

22.5K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

18.0K

Related Experiment Videos

Last Updated: Jan 17, 2026

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

11.3K
Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
09:44

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Published on: June 2, 2019

22.5K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

18.0K

Related Concept Videos

Neural Regulation01:37

Neural Regulation

43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K

Articles linked to this work by shared authors, journal, and citation graph.

Early functional changes and plasma GFAP in Swedish families with Autosomal Dominant Alzheimer's disease mutations.

Translational psychiatry·2026

Profiling Plasma Biomarkers, Particularly pTau217 and pTau217/Aβ42, and Their Relation to Cognition in Memory Clinic Patients.

Journal of neurochemistry·2025

Tau PET positivity predicts clinically relevant cognitive decline driven by Alzheimer's disease compared to comorbid cases; proof of concept in the ADNI study.

Molecular psychiatry·2024

Kinetic Modeling of Brain [18-F]FDG Positron Emission Tomography Time Activity Curves with Input Function Recovery (IR) Method.

Metabolites·2024

Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinic.

Translational psychiatry·2023

Astrocyte Signature in Alzheimer's Disease Continuum through a Multi-PET Tracer Imaging Perspective.

Cells·2023

Epilepsy and education: a nationwide cohort study.

Journal of neurology, neurosurgery, and psychiatry·2026

Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

Journal of neurology, neurosurgery, and psychiatry·2026

Iatrogenic cerebral amyloid angiopathy: a scoping review.

Journal of neurology, neurosurgery, and psychiatry·2026

Associations of self-reported and objectively measured physical activity and amyotrophic lateral sclerosis risk.

Journal of neurology, neurosurgery, and psychiatry·2026

Cerebrospinal fluid haemoglobin as a monitoring biomarker for secondary brain injury after aneurysmal subarachnoid haemorrhage: prospective international multicentre validation study (HeMoVal).

Journal of neurology, neurosurgery, and psychiatry·2026

HLA-dependent association between EBNA1 antibody levels and disability progression in multiple sclerosis.

Journal of neurology, neurosurgery, and psychiatry·2026

Exploring the effect of red and near-infrared light on neurodegenerative disease: A focus on amyotrophic lateral sclerosis, Charcot's devastating disease of the motor system.

International review of neurobiology·2026

Machine learning combined with fMRI identifies dynamic brain network alterations in post-stroke depression: A dual-center cross-sectional study.

Journal of affective disorders·2026

Regenerative medicine for neurodegenerative diseases:History, Strategies, and Clinical Advances.

Translational research : the journal of laboratory and clinical medicine·2026

Emerging molecular mechanism of neuroinflammation in Parkinson's disease: A JAK/STAT and TGFβ/SMAD signaling crosstalk.

Biochimica et biophysica acta. General subjects·2026

Vitamin D receptor FokI polymorphism preferentially modulates cognitive vulnerability in Parkinson's disease: Evidence from an Indian cohort.

Journal of neuroimmunology·2026

Safety and adverse event profiles in neuromodulation therapies for drug-resistant epilepsy.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us